News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Shattuck Labs
NEWS
JOBS
IN THE PRESS
NEWS
Layoffs
Shattuck Labs to Lay Off 40% of Workforce
As it shifts focus to a death receptor 3 (DR3) antagonist antibody, Shattuck Labs is cutting a significant number of employees before the end of the year.
October 1, 2024
·
2 min read
·
Angela Gabriel
Deals
4 Biotech IPOs this Week: Kronos, Shattuck, Spruce and Aziyo
It’s been a fairly busy week for biotech initial public offerings (IPOs) with four announcing their list pricing. Here’s a look.
October 9, 2020
·
4 min read
·
Mark Terry
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins
February 14, 2024
·
3 min read
Business
Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases
February 13, 2024
·
5 min read
Bio NC
Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2024
January 8, 2024
·
7 min read
Bio NC
Shattuck Labs Announces Presentation at Upcoming 42nd Annual J.P. Morgan Healthcare Conference
January 4, 2024
·
1 min read
Bio NC
Shattuck Labs Announces $50 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants
December 21, 2023
·
4 min read
Drug Development
Shattuck Labs Announces Positive Initial Topline Data from Ongoing Phase 1 A/B Dose Expansion Clinical Trial of SL-172154
December 13, 2023
·
10 min read
Drug Development
Shattuck Labs to Host Investor Call & Webcast to Share Initial Clinical Trial Data from Phase 1A/B Dose-Expansion Cohorts in Frontline HR-MDS and TP53m AML and Review of Dose-Escalation Data from the ASH 2023 Annual Meeting on December 13, 2023
December 5, 2023
·
1 min read
Bio NC
Shattuck Labs Announces Participation in Upcoming 6th Annual Evercore ISI HealthCONx Conference
November 14, 2023
·
1 min read
Business
Shattuck Labs Reports Third Quarter 2023 Financial Results and Recent Business Highlights
November 9, 2023
·
15 min read
Business
Shattuck Labs to Report Third-Quarter 2023 Financial Results on November 9, 2023
November 6, 2023
·
1 min read